e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Kobashi Y., Mouri K., Obase Y., Fukuda M., Miyashita N., Oka M.
Source:
Eur Respir J 2007; 30: 945-950
Journal Issue:
November
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kobashi Y., Mouri K., Obase Y., Fukuda M., Miyashita N., Oka M.. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007; 30: 945-950
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation
Clinical characteristics of female and male sarcoidosis patient
IGG immune response against MPT-64, CFP-10 and ESAT-6 antigens in children with pulmonary tuberculosis
Related content which might interest you:
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice
Source: Eur Respir J 2009; 33: 812-815
Year: 2009
Comparison of QuantiFERON-TB Gold test and tuberculin skin test in diagnosis of pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 133s
Year: 2007
Quantiferon and tuberculin skin test for detection of tuberculosis infection in immunocompromised patients
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
The tuberculin skin test and QuantiFERON test comparison in the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Prednisolone treatment does affect the performance of the QuantiFERON in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
Discordance QuantiFERON-TB Gold in-tube and tuberculin skin test: Latent tuberculosis infection or immunological memory?
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection
Source: Eur Respir J 2013; 41: 909-916
Year: 2013
Diagnosing TB infection in children: analysis of discordances using in vitro tests and the tuberculin skin test
Source: Eur Respir J 2011; 37: 1166-1174
Year: 2011
Evaluation of latent tuberculosis infection in health care workers by QuantiFERON-TB Gold test and tuberculin skin test
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Comparation of QFT-GIT test and tubeculine skin test in patients with sarcoidosis
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Clinical utility of the quantiFERON TB-2G test for elderly patients with active tuberculosis
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Importance of QuantiFERON-TB Gold and tuberculin skin test in the differential diagnosis of active and inactive pulmonary tuberculosis
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
The QuantiFERON-TB Gold test at HIV patients
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Tuberculin skin test and IGRA test in the diagnosis and follow-up of bacteriologically confirmed pulmonary tuberculosis in HIV negative adults
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Clinical evaluation of QuantiFERON TB-2G test for patients with active tuberculosis disease stratified by age groups
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Clinical evaluation of QuantiFERON TB -2g test in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept